These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 12568221)
1. Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study. McDonald C; Uy J; Hu W; Wirtz V; Juethner S; Butcher D; McGrath D; Farajallah A; Moyle G AIDS Patient Care STDS; 2012 May; 26(5):259-64. PubMed ID: 22404426 [TBL] [Abstract][Full Text] [Related]
3. Post-exposure prophylaxis. van der Ende ME; Regez RM; Schreij G; van der Meer JT; Danner SA; Int J STD AIDS; 2002 Dec; 13 Suppl 2():30-4. PubMed ID: 12537723 [TBL] [Abstract][Full Text] [Related]
4. Buffalo hump: what the experts suggest. Piliero PJ; McComsey GA AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294 [No Abstract] [Full Text] [Related]
5. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ; Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012 [TBL] [Abstract][Full Text] [Related]
6. The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir. Nouts C; Bonarek M; Morlat P; Delevaux I; Bonnet F; Lacoste D; Bernard N; Beylot J Int J STD AIDS; 2001 Jan; 12(1):29-33. PubMed ID: 11177479 [TBL] [Abstract][Full Text] [Related]
9. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria. Perazella MA; Kashgarian M; Cooney E Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425 [TBL] [Abstract][Full Text] [Related]
10. A review of low-dose ritonavir in protease inhibitor combination therapy. Cooper CL; van Heeswijk RP; Gallicano K; Cameron DW Clin Infect Dis; 2003 Jun; 36(12):1585-92. PubMed ID: 12802760 [TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of antiretroviral therapy in an HIV-infected patient. Said SM; Nasr SH; Samsa R; Markowitz GS; D'Agati VD Kidney Int; 2007 May; 71(10):1071-5. PubMed ID: 17311070 [No Abstract] [Full Text] [Related]
12. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part I. Boyle BA AIDS Read; 2001 Jul; 11(7):354-5, 359-61, 363. PubMed ID: 11494705 [No Abstract] [Full Text] [Related]